Intranasal medication stops Alzheimer's memory loss in early tests
Intranasal administration of active lipid messengers blocks memory loss and neurodegeneration in mouse models of Alzheimer's.
Read moreIntranasal administration of active lipid messengers blocks memory loss and neurodegeneration in mouse models of Alzheimer's.
Read moreAducanumab could represent a revolution for all Alzheimer's patients, but for now it represents only an element of controversy
Read moreThe "blood-brain" pathway that intoxicates the latter, producing Alzheimer's degeneration, could originate from the liver.
Read moreA blood sample, 10 minutes of testing and very high accuracy: here's how a new algorithm can change the diagnosis ...
Read moreTwo new studies promote light neurofilament, a particular protein, as a promising early indicator of neurodegenerative diseases.
Read moreThe test showed "remarkable and clinically important" results. Patients undergoing treatment have regained a year of capacity ...
Read moreThe Alzheimer's vaccine will be ready within 5 years. A good result, for a disease that frightens many ...
Read moreTo submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.
© 2022 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.